These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28031459)

  • 21. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of neuronal nicotinic acetylcholine receptor α4β2 activation at the single-channel level.
    Carignano C; Barila EP; Spitzmaul G
    Biochim Biophys Acta; 2016 Sep; 1858(9):1964-1973. PubMed ID: 27233449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.
    Grupe M; Jensen AA; Ahring PK; Christensen JK; Grunnet M
    Br J Pharmacol; 2013 Apr; 168(8):2000-10. PubMed ID: 23278456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.
    Carbone AL; Moroni M; Groot-Kormelink PJ; Bermudez I
    Br J Pharmacol; 2009 Mar; 156(6):970-81. PubMed ID: 19366353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.
    Benallegue N; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2013 Sep; 170(2):304-16. PubMed ID: 23742319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamus.
    Fasoli F; Moretti M; Zoli M; Pistillo F; Crespi A; Clementi F; Mc Clure-Begley T; Marks MJ; Gotti C
    Neuropharmacology; 2016 Sep; 108():324-31. PubMed ID: 27157710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological and functional comparisons of α6/α3β2β3-nAChRs and α4β2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line.
    Chen DJ; Gao FF; Ma XK; Shi GG; Huang YB; Su QX; Sudweeks S; Gao M; Dharshaun T; Eaton JB; Chang YC; Mcintosh JM; Lukas RJ; Whiteaker P; Steffensen SC; Wu J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1571-1581. PubMed ID: 29795357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.
    Mazzaferro S; Benallegue N; Carbone A; Gasparri F; Vijayan R; Biggin PC; Moroni M; Bermudez I
    J Biol Chem; 2011 Sep; 286(35):31043-31054. PubMed ID: 21757735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concatemers to re-investigate the role of α5 in α4β2 nicotinic receptors.
    Prevost MS; Bouchenaki H; Barilone N; Gielen M; Corringer PJ
    Cell Mol Life Sci; 2021 Feb; 78(3):1051-1064. PubMed ID: 32472188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stoichiometry-Selective Antagonism of α4β2 Nicotinic Acetylcholine Receptors by Fluoroquinolone Antibiotics.
    Sanders VR; Sweeney A; Topf M; Millar NS
    ACS Chem Neurosci; 2022 Jun; 13(12):1805-1817. PubMed ID: 35657695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
    Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
    Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types.
    Moroni M; Bermudez I
    J Mol Neurosci; 2006; 30(1-2):95-6. PubMed ID: 17192644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacy.
    Mazzaferro S; Gasparri F; New K; Alcaino C; Faundez M; Iturriaga Vasquez P; Vijayan R; Biggin PC; Bermudez I
    J Biol Chem; 2014 Aug; 289(31):21795-806. PubMed ID: 24936069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.
    Kuryatov A; Onksen J; Lindstrom J
    Mol Pharmacol; 2008 Jul; 74(1):132-43. PubMed ID: 18381563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI.
    Deba F; Munoz K; Peredia E; Akk G; Hamouda AK
    J Biol Chem; 2022 Jan; 298(1):101455. PubMed ID: 34861241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
    Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
    PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.